Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8008021rdf:typepubmed:Citationlld:pubmed
pubmed-article:8008021lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:8008021lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:8008021lifeskim:mentionsumls-concept:C0023276lld:lifeskim
pubmed-article:8008021lifeskim:mentionsumls-concept:C0205173lld:lifeskim
pubmed-article:8008021lifeskim:mentionsumls-concept:C0872178lld:lifeskim
pubmed-article:8008021lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:8008021lifeskim:mentionsumls-concept:C1332838lld:lifeskim
pubmed-article:8008021pubmed:issue2lld:pubmed
pubmed-article:8008021pubmed:dateCreated1994-7-21lld:pubmed
pubmed-article:8008021pubmed:abstractTextThe Leishmania major single-stranded DNA binding protein HEXBP contains nine 'CCHC' zinc finger motifs and binds to oligodeoxynucleotides derived from the antisense strand of the GP63 gene 5' flanking region in gel mobility shift assays and UV-crosslinking assays. In the present study a HEXBP-deficient clone of L. major was generated by double targeted gene replacement. The two HEXBP alleles were sequentially replaced with genes encoding resistance to the aminoglycoside antibiotics hygromycin B and G418 and drug-resistant clones were selected by plating on semi-solid drug-containing media. Successful deletion of both copies of the HEXBP gene implies that HEXBP is a not essential for growth of Leishmania promastigotes. Characterization HEXBP-deficient promastigotes revealed that HEXBP deficiency had no effect on the abundance of GP63 mRNA and protein in in vitro cultivated promastigotes and that HEXBP-deficient promastigotes were capable of lesion formation in BALB/c mice.lld:pubmed
pubmed-article:8008021pubmed:languageenglld:pubmed
pubmed-article:8008021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:citationSubsetIMlld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8008021pubmed:statusMEDLINElld:pubmed
pubmed-article:8008021pubmed:monthFeblld:pubmed
pubmed-article:8008021pubmed:issn0166-6851lld:pubmed
pubmed-article:8008021pubmed:authorpubmed-author:WebbJ RJRlld:pubmed
pubmed-article:8008021pubmed:authorpubmed-author:McMasterW RWRlld:pubmed
pubmed-article:8008021pubmed:issnTypePrintlld:pubmed
pubmed-article:8008021pubmed:volume63lld:pubmed
pubmed-article:8008021pubmed:ownerNLMlld:pubmed
pubmed-article:8008021pubmed:authorsCompleteYlld:pubmed
pubmed-article:8008021pubmed:pagination231-42lld:pubmed
pubmed-article:8008021pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:meshHeadingpubmed-meshheading:8008021-...lld:pubmed
pubmed-article:8008021pubmed:year1994lld:pubmed
pubmed-article:8008021pubmed:articleTitleLeishmania major HEXBP deletion mutants generated by double targeted gene replacement.lld:pubmed
pubmed-article:8008021pubmed:affiliationDepartment of Medical Genetics, University of British Columbia, Vancouver, Canada.lld:pubmed
pubmed-article:8008021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8008021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8008021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8008021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8008021lld:pubmed